We acknowledge that a great heterogeneity of PD-L1 expression data emerged due to the cut-off points chosen by each study, the dilution and type of antibody used, and the reported data on expression (PD-L1 expression on tumor cells, CPS—“combined positive score”, and TPS—“tumor proportion score”). This evidence concerns the gene CD274 and neoplasm.